Last updated: August 6, 2025
Introduction
Japan Patent JP5752048, granted in 2018, pertains to innovations in pharmaceutical compounds and their therapeutic applications. A thorough understanding of its scope, claims, and the surrounding patent landscape is crucial for stakeholders in drug development, licensing, and patent strategy in Japan’s highly competitive pharmaceutical sector. This analysis deciphers the specific claims, evaluates the patent's breadth, and contextualizes its position within the global patent environment.
Patent Overview and Technical Field
JP5752048 addresses novel chemical entities, formulations, and methods for treating specific diseases, likely focusing on a class of compounds with therapeutic relevance. Based on the patent's classification, it falls under the International Patent Classification (IPC) section A61K (clks. for medical or veterinary science; hygiene) and C07D (heterocyclic compounds), indicating its focus on medicinal chemistry involving heterocycles or other bioactive structures.
The patent aims to secure exclusive rights over certain innovative derivatives or uses of compounds, offering potential competitive advantage in treatments such as oncology, neurology, or inflammatory conditions.
Scope and Claims
Independent Claims
The independent claims define the core scope of the patent and form the boundaries for enforcement and licensing:
-
Chemical Structure and Derivatives:
Claims likely cover a broad class of chemical compounds characterized by a core heterocyclic structure with optional substitutions. These broad claims aim to include all derivatives that share the essential pharmacophore, ensuring wide protective coverage.
-
Pharmacological Use:
Claims probably encompass methods of using these compounds for the treatment or prevention of specific diseases or conditions, such as certain cancers or neurodegenerative disorders. This dual approach—composition and method claims—strengthens enforceability.
-
Formulations and Compositions:
Composition claims may extend to pharmaceutical formulations, including novel dosage forms, delivery mechanisms, or combinations with other active ingredients.
Dependent Claims
Dependent claims typically specify particular embodiments, such as:
- Specific chemical substituents.
- Pharmacokinetic or pharmacodynamic properties.
- Preferred formulations or dosages.
- Method-specific features like routes of administration.
These narrow claims serve to reinforce the patent's
